Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
KBR Announces Intent to Build Human Spaceflight Innovation Facility at ACMI Properties’ Exploration Park, Supporting Missions to Mars, the Moon, and In-Orbit
From ACMI Group
Via GlobeNewswire
Tickers KBR
The Coastal Companies Issues Voluntary Recall on Items With Fresh Start Cucumbers Due to the Potential for Salmonella Contamination
From Sysco Corporation
Via GlobeNewswire
Tickers SYY
KBR Signs Letter of Intent to Develop Spaceflight Food Lab at Exploration Park Near Johnson Space Center
From Kellogg Brown & Root LLC.
Via GlobeNewswire
Tickers KBR
Iovance Announces Five-year Results of Amtagvi® (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Tickers IOVA
Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC
From Merus N.V.
Via GlobeNewswire
Tickers MRUS
Allogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Poster for Cema-Cel
From Allogene Therapeutics, Inc.
Via GlobeNewswire
Tickers ALLO
Daktronics to Participate in the 22nd Annual Craig-Hallum Institutional Investor Conference on May 28th
From Daktronics, Inc.
Via GlobeNewswire
Tickers DAKT
ImCheck Reports High Remission Rates in AML Patients with ICT01 Combination Therapy at ASCO 2025
From ImCheck Therapeutics SAS
Via GlobeNewswire
Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025
From Cullinan Therapeutics, Inc.; Taiho Pharmaceutical Co., Ltd.; Taiho Oncology, Inc.
Via GlobeNewswire
Tickers CGEM
Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
From Legend Biotech USA Inc.
Via GlobeNewswire
Tickers LEGN
Menarini Group Presents Updated Data Underscoring the Combinability of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2025 Annual Meeting
From Stemline Therapeutics, Inc.
Via GlobeNewswire
ROHM Develops Compact Surface-Mount Near-Infrared LEDs Featuring Industry-Leading Radiant Intensity
From ROHM Semiconductor
Via GlobeNewswire
Boehringer Ingelheim to present early clinical evidence of innate immune modulation and anti-tumor activity via SIRPα blockade in two ongoing trials at ASCO 2025
From Boehringer Ingelheim Limited
Via GlobeNewswire
Candel Therapeutics Presents Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025
From Candel Therapeutics
Via GlobeNewswire
Tickers CADL
Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting
From Adagene Inc.
Via GlobeNewswire
Tickers ADAG
Avidicure to Present Preclinical Data from Lead TROP2-targeting Multifunctional Antibody Program at the 2025 American Society of Clinical Oncology Annual Meeting
From Avidicure
Via GlobeNewswire
Lyme Timber Receives the 2025 SFI Leadership in Conservation Award for Advancing Nature-Based Solutions in SFI-Certified Forests
From Sustainable Forestry Initiative
Via GlobeNewswire
Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting
From Biodesix, Inc.
Via GlobeNewswire
Tickers BDSX
Linvoseltamab in Combination with Carfilzomib or Bortezomib Shows Promising Initial Results in Earlier Lines of Treatment for Relapsed/Refractory Multiple Myeloma
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers REGN
Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
Bicara Therapeutics Announces Publication of an Abstract with Updated Interim Data from Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 ASCO Annual Meeting
From Bicara Therapeutics Inc.
Via GlobeNewswire
Tickers BCAX
Cal Redwood Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering
From Cal Redwood Acquisition Corp.
Via GlobeNewswire
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
From Onconetix, Inc.
Via GlobeNewswire
Tickers ONCO
“Finish Line Campaign” Erases More than $83,000 of debt for Howard Community College Graduates, Continuing Students
From Howard Community College
Via GlobeNewswire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers TMCI
China's First Laozi Digital Human Unveiled in Sanmenxia, Henan
From The Organizing Committee of Sanmenxia Yellow River Cultural Tourism Festival
Via GlobeNewswire
Guggenheim Second Quarter 2025 High Yield and Bank Loan Outlook: Credit Crossroads: Finding Value in an Era of Uncertainty
From Guggenheim Partners Investment Management Holdings, LLC
Via GlobeNewswire
ESET participates in operation to disrupt the infrastructure of Danabot infostealer
From ESET
Via GlobeNewswire
Crown LNG Holdings Limited Discloses Receipt of NASDAQ Notice
From Crown LNG
Via GlobeNewswire
Tickers CGBS
Athene Holding Ltd. Declares Second Quarter 2025 Preferred Stock Dividends
From Athene Holding Ltd.
Via GlobeNewswire
Tickers ATH
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.